Gold, L. S., Weiss, J. S., Green, L., Kircik, L., Miller, L., Jacobson, A., & Harris, S. (2020). Long-Term Management of Moderate-to-Severe Plaque Psoriasis: Maintenance of Treatment Success Following Cessation of Fixed Combination Halobetasol Propionate 0.01% and Tazarotene 0.045% (HP/TAZ) Lotion in Patients with Baseline Body Surface Area of 6 -12%. SKIN The Journal of Cutaneous Medicine, 4(5), s37.